Two Perthshire women have worked with some of the world’s leading nutraceutical companies to launch a supplement designed to tackle menopause symptoms.
Following months of rigorous research and development, Selaura officially launched its new product during National Menopause Month.
Selaura is the brainchild of former lawyer Morven Shaw and holistic therapist Debbie Wheeler, when aged 44 and 53 they found themselves at various stages of menopause.
With no constructive solutions available on the market other than vitamins or non-clinically proven supplements, and the advice to “wait it out” and accept that this was their new normal, the duo decided to take charge.
Morven and Debbie firmly believe the 13 million women in the UK who are currently peri or menopausal should “age and enjoy life without hormonal compromise”.
Formulated by women for women, the supplement combines 12 ingredients, designed to alleviate the physical and emotional symptoms of peri and menopause which often start from late 30s and can last up to 15 years.
“We’re thrilled to launch our intelligent female supplement which is set to be a game-changer for the third of the UK female population who are peri or menopausal,” Morven said.
“Our aim with Selaura was simply to help women continue to live and love their lives, without compromise, by redressing the symptoms that affect so many of us.
“The word menopause is associated with getting old, despite the fact that perimenopause usually starts around the age of 40 – and often even younger than that.
She added: “Women have suffered in silence, dismissing these symptoms down to the stress and strains of everyday life.
“Selaura helps us to take back control.”
Debbie added: “Creating a premium supplement with maximum efficacy to support the ongoing health and wellbeing of women in their 40s plus has been key for us.
“There was also a desire from the outset for a well-balanced supplement using scientific formulations and completely natural products, with the highest grade ingredients, their effects proven by clinical research.”
